Real-World Evidence (RWE) has become an integral component of drug and medical device development, as well as of Health Economics & Outcomes Research (HEOR). Serving as a complement to conventional randomized clinical trials (RCTs), Real-World Evidence collects supporting outcomes and safety data beyond RCTs, that provide a more comprehensive view of a product's real-life therapeutic and economic value to patients, payers, providers and sponsors. With the right data and analytics support, Real-World Evidence informs a common understanding of a drug or device efficacy and safety profile that is used by multiple healthcare stakeholders to drive decisions.
Please enter valid quantity
Please login to add favorites
NULL OR EMPTY CART
You successfully added item(s) to your cart
Our Real-World Evidence solution, leveraging TIBCO Spotfire®, accelerates time to insight with pre-built analysis modules that create the possibility to conduct an end-to-end analysis in one place: